Potato chip recall upgraded to highest FDA risk level over salmonella concerns
The FDA has upgraded a potato chip recall to its highest risk level due to salmonella concerns, affecting popular brands.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The FDA has elevated a recall of certain potato chip brands to Class I, its most serious risk level. The recall is due to potential salmonella contamination. Coverage emphasizes the brands affected, including Utz Zapp's and Dirty chips.
Outlets reporting include WESH, FOX21 News Colorado, Detroit Free Press, Yahoo, AL.com, The Guardian, FOX 8 News, MySA, WKRC, USA Today, WGAL, and ABC7 Los Angeles. The recall's scope and the specific brands involved are highlighted. The Detroit Free Press provides information on where the recalled chips were sold.
Watch for updates on the extent of the recall and any additional brands or products that may be affected. Coverage does not yet specify the timeline for the recall or consumer guidance.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 3h ago.
Quick answers
Which potato chip brands are affected by the recall?
The recall affects Utz Zapp's and Dirty chips, according to coverage from Yahoo and AL.com.
What is the FDA's highest risk level?
The FDA's highest risk level is Class I, which indicates a situation where there is a reasonable probability that the use of the product will cause serious adverse health consequences or death.
Where were the recalled potato chips sold?
The Detroit Free Press reports on the locations where the recalled chips were sold.
Coverage (17)
- FDA reclassifies major potato chip recall to highest level WMTV 15 NEWS · 4h ago
- Utz Potato Chip Recall Receives FDA’s Highest Risk Level Due to Possible Salmonella Contamination TODAY.com · 4h ago
- FDA’s Highest-Risk Potato Chip Recall Arrives Just in Time for the 4th of July Gizmodo · 5h ago
- 650K bags of chips recalled at highest FDA level over salmonella The News Journal · 5h ago
- FDA upgrades potato chip recall to Class I over salmonella risk WESH · 5h ago
- Potato chip recall elevated to FDA’s highest risk level FOX21 News Colorado · 5h ago
- Potato chips recalled over salmonella fears. Where they were sold Detroit Free Press · 5h ago
- FDA upgrades Utz Zapp's and Dirty chip recall to Class I Yahoo · 5h ago
- Recall of popular potato chips upgraded to highest FDA risk over salmonella fears AL.com · 5h ago
- FDA issues most serious recall alert for potato chip brands over salmonella risk The Guardian · 5h ago
- Popular chip recall now highest FDA risk FOX 8 News · 5h ago
- Recall of popular potato chips classified under FDA's highest risk level Yahoo · 18h ago
- Popular chips given highest risk level over salmonella concerns MySA · 1d ago
- Potato chips recalled by massive snack company, potentially contaminated with salmonella WKRC · 1d ago
- Recall of popular potato chips classified under FDA's highest risk level USA Today · 1d ago
- FDA upgrades potato chip recall to Class I over salmonella risk WGAL · 1d ago
- Potato chip recall upgraded to highest FDA risk level over salmonella concerns ABC7 Los Angeles · 1d ago
Topics
Related trends
Exclusive: FDA allows ZYN to sell pouches on health benefits
The FDA's decision to allow Philip Morris to market ZYN nicotine pouches as safer than cigarettes is sparking debate.
FDA’s top gene therapy regulator is leaving his role
The FDA's top gene therapy regulator is stepping down, amid a significant setback for a kidney disease drug.
FDA panel on peptides will include experts who promote the unproven chemicals favored by RFK Jr.
FDA staff raise concerns about peptides as advisory panel with proponents of the molecules is announced
Nearly 100K Hyundai vehicles recalled after software glitch raises crash risk
Hyundai recalls nearly 100,000 vehicles due to a software glitch that could cause crashes.
Eli Lilly, Regeneron among first companies selected for FDA initiative to speed review of new manufacturing facilities
The FDA is launching a pilot program to accelerate the review process for new pharmaceutical manufacturing facilities, starting with Eli Lilly and Regeneron.
Supplements sold online through major retailers recalled nationwide over potential salmonella risk
Major retailers are recalling supplements sold online due to potential salmonella contamination.